Tag: Aaron DiAntonio November 4, 2022 Understanding, treating pain, reducing opioid use, aim of $11.7 million grantFunding from NIH HEAL Initiative.News Release October 26, 2022 New strategy shows potential to block nerve loss in neurodegenerative diseasesResearch into how key molecule triggers axon death may lead to new therapies.News Release October 28, 2021 Inventive pathways: A research powerhouse becomes an innovation incubatorTurning research discoveries into real-world solutions can mean a decade of challenges. WashU is working to clear the way.Outlook Magazine November 24, 2020 AAAS names 7 Washington University faculty as 2020 fellowsFour of the newly named fellows are School of Medicine faculty.Medical Campus & Community October 20, 2020 Startup company founded by Washington University scientists acquired by Eli LillyDrugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.Medical Campus & Community July 29, 2019 Extending human lifeTwo new centers focus on chronic diseases of aging.Outlook Magazine February 20, 2019 Needlemans commit $15 million aimed at therapies for chronic diseasesNew centers’ researchers will target chronic diseases of aging.News Release January 16, 2019 Gene therapy blocks peripheral nerve damage in miceLays groundwork for developing treatments for peripheral neuropathy, other nerve diseases.News Release December 4, 2017 Pursuing a precision paradigmMedical school experts describe the move from current standards of care to a more personalized approach to treatment.Source: Washington Magazine March 22, 2017 Surprising culprit in nerve cell damage identifiedFindings suggest ways to block nerve cell damage in neurodegenerative diseases.News Release Posts navigation